Dimensional Fund Advisors’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,333
Closed -$50.4K 3352
2024
Q3
$50.4K Hold
11,333
﹤0.01% 3300
2024
Q2
$48.7K Hold
11,333
﹤0.01% 3318
2024
Q1
$47K Hold
11,333
﹤0.01% 3334
2023
Q4
$52K Buy
+11,333
New +$43K ﹤0.01% 3343
2023
Q3
Sell
-1,579
Closed -$8.84K 3481
2023
Q2
$8.84K Sell
1,579
-962
-38% -$6.39K ﹤0.01% 3475
2023
Q1
$16.2K Hold
2,541
﹤0.01% 3445
2022
Q4
$38 Hold
2,541
﹤0.01% 3419
2022
Q3
$16K Hold
2,541
﹤0.01% 3468
2022
Q2
$28K Sell
2,541
-4,983
-66% -$73.4K ﹤0.01% 3435
2022
Q1
$156K Buy
7,524
+400
+6% +$11.1K ﹤0.01% 3340
2021
Q4
$281K Buy
7,124
+4,901
+220% +$234K ﹤0.01% 3286
2021
Q3
$115K Buy
+2,223
New +$86.5K ﹤0.01% 3416

Other funds holding EDSA

Dimensional Fund Advisors's EDSA Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of Edesa Biotech (EDSA) in Q4 2024, closing a stake of 11,333 shares — an estimated $50.4K sold.

Dimensional Fund Advisors first reported a position in EDSA in Q3 2021 and held it in 12 quarters. The position peaked at $281K in Q4 2021. 17 funds tracked by Wall St. Rank hold EDSA as of Q4 2024.

  • Dimensional Fund Advisors reported no remaining Edesa Biotech position as of Q4 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 11,333 Edesa Biotech shares in Q4 2024, an estimated $50.4K.
  • Dimensional Fund Advisors first reported a position in Edesa Biotech in Q3 2021 and held it in 12 quarters.
  • Dimensional Fund Advisors's Edesa Biotech position peaked at $281K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.